Taking people in SpainPhase 1
Tests loncastuximab tesirine with other cancer drugs for lymphoma that returned
Tests loncastuximab tesirine with other drugs in adults with returned lymphoma.
Plain-language title generated from the registry record
Registry title: A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Key facts
- Where
- L'Hospitalet de Llobregat, Madrid, Salamanca, and Valencia, SpainSee the 5 sites
- Phase
- Phase 1
Where in Spain
- Institut Catala D'oncologiaL'Hospitalet de Llobregat, SpainTaking people
- Fundacion Para La Investigacion Biomedica Del Hospital Gregorio MaranonMadrid, SpainTaking people
- Hospital Universitario Ramón y CajalMadrid, SpainTaking people
- Hospital Universitario De SalamancaSalamanca, SpainTaking people
- Hospital Universitario Y Politecnico La FeValencia, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- ADC Therapeutics SA
- Trial code
- NCT04970901EU 2024-512089-32-00
- Record updated
- 15 September 2026